Fibrinogen Early In Severe Trauma studY (FEISTY)
Fibrinogen Concentrate vs Cryoprecipitate in Traumatic Haemorrhage: A Pilot Randomised Controlled Trial
Sponsor: Australian Red Cross
Listed as NCT02745041, this PHASE2 trial focuses on Coagulopathy and Haemorrhage and remains completed. Sponsored by Australian Red Cross, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Completed PHASE2
Status: Recruiting → Completed
▶ Show 2 earlier versions
-
Jun 2017 — Mar 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Jun 2017 [monthly]
Recruiting PHASE2
First recorded
Dec 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Australian Red Cross
- Emergency Medicine Foundation
- Gold Coast Hospital and Health Service
- National Blood Authority
For direct contact, visit the study record on ClinicalTrials.gov .